Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-36612628

ABSTRACT

The tissue inhibitors of metalloproteinases-3 (TIMP3) are not only endogenous regulators of matrix metalloproteinases (MMPs), but also induce apoptosis and inhibit endothelial cell migration and angiogenesis. The focus of this study was to investigate the relationship between TIMP3 genetic polymorphisms and biochemical recurrence and clinicopathological features of prostate cancer. The TIMP3 rs9619311, rs9862, and rs11547635 genetic polymorphisms were analyzed by real-time polymerase chain reaction to determine their genotypic distributions in 579 patients with prostate cancer. This study found that individuals with the TIMP3 rs9619311 TC or TC + CC genotypes have a significantly higher risk of biochemical recurrence of prostate cancer (p = 0.036 and 0.033, respectively). Moreover, in the multivariate analysis, our results showed that pathologic Gleason grade, pathologic T stage, seminal vesicle invasion, lymphovascular invasion, and TIMP3 rs9619311 were associated with increased odds of biochemical recurrence. Patients with a PSA concentration under 7 ng/mL that were found to have the TIMP3 rs9619311 genetic polymorphism were associated with Gleason total score upgrade (p = 0.012) and grade group upgrade (p = 0.023). Compared with the CC homozygous, the TIMP3 rs9862 CT + TT polymorphic variant was found to be associated with clinically advanced tumor stage (p = 0.030) and Gleason total score upgrade (p = 0.002) in prostate cancer patients. In conclusion, the results of our study demonstrated that the TIMP3 rs9619311 genetic polymorphism was significantly associated with susceptibility to biochemical recurrence of prostate cancer. TIMP3 genetic polymorphisms, especially rs9619311, can serve as key predictors of biochemical recurrence and disease prognosis of prostate cancer.


Subject(s)
Prostatic Neoplasms , Tissue Inhibitor of Metalloproteinase-3 , Male , Humans , Tissue Inhibitor of Metalloproteinase-3/genetics , Prostatic Neoplasms/genetics , Prostatic Neoplasms/pathology , Polymorphism, Genetic , Genotype , Metalloproteases/genetics , Prostate-Specific Antigen
2.
Article in English | MEDLINE | ID: mdl-33228130

ABSTRACT

Prostate cancer is among the most common malignant tumors worldwide. Matrix metalloproteinase (MMP)-11 is involved in extracellular matrix degradation and remodeling and plays an essential role in cancer development and metastasis. This study investigated the association of MMP-11 polymorphisms with the clinicopathological characteristics and biochemical recurrence of prostate cancer. Five single-nucleotide polymorphisms (SNPs) of the MMP-11 were analyzed in 578 patients with prostate cancer through real-time polymerase chain reaction analysis. A prostate-specific antigen level of >10 ng/mL, Gleason grade groups 4 + 5, advanced tumor stage, lymph node metastasis, invasion, and high-risk D'Amico classification were significantly associated with biochemical recurrence in the patients (p < 0.001). MMP-11 rs131451 "TC + CC" polymorphic variants were associated with advanced clinical stage (T stage; p = 0.007) and high-risk D'Amico classification (p = 0.015) in patients with biochemical recurrence. These findings demonstrate that MMP-11 polymorphisms were not associated with prostate cancer susceptibility; however, the rs131451 polymorphic variant was associated with late-stage tumors and high-risk D'Amico classification in prostate cancer patients with biochemical recurrence. Thus, the MMP-11 SNP rs131451 may contribute to the tumor development in prostate cancer patients with biochemical recurrence.


Subject(s)
Matrix Metalloproteinase 11 , Prostatic Neoplasms , Humans , Male , Matrix Metalloproteinase 11/genetics , Neoplasm Grading , Neoplasm Staging , Polymorphism, Single Nucleotide , Prostatic Neoplasms/enzymology , Prostatic Neoplasms/genetics , Prostatic Neoplasms/pathology , Recurrence
3.
Curr Environ Health Rep ; 6(3): 188-199, 2019 09.
Article in English | MEDLINE | ID: mdl-31372861

ABSTRACT

BACKGROUND: Urinary biomonitoring is widely used to assess environmental chemical exposure; however, a critical gap exists in whether and how to correct for the physiological variation in water content of spot urine samples. OBJECTIVE: The aim of this systematic review is to summarize the available evidence comparing the performance of urinary concentration correction methods used to determine urinary levels of arsenic, cadmium, and mercury. METHODS: We searched PubMed/MEDLINE, Embase, LILIAC, Web of Science, and TOXNET up to Sept. 5, 2017 for articles evaluating urinary concentration correction methods (e.g., urine creatinine [U-Cre], specific gravity [U-SG], osmolality [U-Osm]) compared to 24-h or timed urine specimens for levels of arsenic, cadmium, and mercury. Data on study design, methods of urine collection, and the performance of selected correction methods were extracted. RESULTS: A total of 10 papers met the inclusion criteria. Two papers evaluated the performance of urinary concentration correction methods for arsenic, four for cadmium, three for mercury, and one for multiple metals. The median sample size for arsenic was 105, for cadmium 107, and for mercury 35. The studies were highly heterogeneous in population selection, urine collection, urine quality control, statistical comparison among selected correction methods, and presentation of the results. The median (range) of correlation coefficients comparing each corrected values with corresponding levels of timed urine specimens are 0.74 (0.17-0.92) for un-correction (n = 13), 0.82 (0.52-0.98) for U-Cre (n = 13), and 0.75 (0.28-0.98) (n = 12) for U-SG. CONCLUSION: Findings from limited evidence support that urine creatinine and urine-specific gravity corrections remain practical approaches to correct metal concentrations for urine dilution as compared to 24-h or 12-h urine samples. Further studies with larger sample sizes are needed to clarify this fundamental issue of environmental biomonitoring using spot urine samples in both general and priority populations.


Subject(s)
Arsenic/urine , Cadmium/urine , Environmental Exposure/analysis , Environmental Pollutants/urine , Mercury/urine , Biomarkers/urine , Female , Humans , Specific Gravity , Urinalysis/methods
4.
Sci Total Environ ; 644: 1625-1629, 2018 Dec 10.
Article in English | MEDLINE | ID: mdl-30743875

ABSTRACT

The UV-filter benzophenone-3 (BP-3) is widely used and is environmentally stable, lipophilic, and bioaccumulative. Previous in vitro and in vivo studies have shown that BP-3 can cause endocrine disrupting effects. However, little information is available on its ecotoxicity on coral reef fish. Agonistic behavior, which is regulated by the endocrine system, is crucial to the social structure of some coral reef fish species. Endocrine disruptors may disturb fish agonistic behavior and social interactions. In this study, we tested whether chronic BP-3 exposure can affect social behaviors in coral reef fish. Juvenile false clown anemonefish (Amphiprion ocellaris) were exposed to BP-3 via diet (0 and 1000 ng/g food) for 90 d. Through the experiment, each tank was videotaped and behavioral indicators of social status, including threatening, attacking, and submissive behaviors were quantitatively analyzed from the videos. Survival and growth were not affected by the BP-3 exposure except that the body weight of the dominant fish was higher in the BP-3 group. Social rankings were not changed by BP-3. Intra-colonial social behaviors were significantly affected only by rank but not by the BP-3 exposure. Our results suggest that BP-3 at environmental levels may not cause significant harm to social behavior of coral reef fish. However, more research is needed to better understand the behavioral effects of BP-3 in fish.


Subject(s)
Benzophenones/toxicity , Perciformes/physiology , Water Pollutants, Chemical/toxicity , Animals , Coral Reefs , Endocrine Disruptors/toxicity
5.
Mar Pollut Bull ; 124(2): 760-766, 2017 Nov 30.
Article in English | MEDLINE | ID: mdl-28034494

ABSTRACT

Aggressive behavior is crucial for maintaining social hierarchy in anemonefish. Endocrine disrupting chemicals such as EE2 may affect fish social hierarchy via disrupting their aggression. In this study, we aimed to characterize the effects of 17α-ethinylestradiol (EE2) on aggressive behavior and social hierarchy in the false clown anemonefish (Amphiprion ocellaris). In the laboratory experiment, juvenile anemonefish were randomly distributed to separated tanks to form small colonies of three individuals and were fed with EE2-dosed diet (100ng/g food) or a control diet for 90d. Through the experiment, each tank was videotaped and behavioral indicators of social status, including aggressive behavior, submissive response, and shelter utilization, were quantitatively analyzed from the videos. The EE2 exposure caused a higher frequency of intra-colonial aggressive interactions and a less stable social hierarchy. Our findings demonstrate the importance of examining the effects of endocrine disrupting chemicals on the social behavior of coral reef fish.


Subject(s)
Aggression/drug effects , Endocrine Disruptors/pharmacology , Ethinyl Estradiol/pharmacology , Hierarchy, Social , Perciformes , Animals , Fishes
6.
Opt Express ; 23(11): A576-81, 2015 Jun 01.
Article in English | MEDLINE | ID: mdl-26072882

ABSTRACT

Increasing studies report blue light to possess a potential hazard to the retina of human eyes, secretion of melatonin and artworks. To devise a human- and artwork-friendly light source and to also trigger a "Lighting Renaissance", we demonstrate here how to enable a quality, blue-hazard free general lighting source on the basis of low color-temperature organic light emitting diodes. With the use of multiple candlelight complementary emitters, the sensationally warm candle light-style emission is proven to be also drivable by electricity. To be energy-saving, highly efficient candle-light emission is demanded. The device shows, at 100 cd m-2 for example, an efficacy of 85.4 lm W-1, an external quantum efficiency of 27.4%, with a 79 spectrum resemblance index and 2,279 K color temperature. The high efficiency may be attributed to the candlelight emitting dyes with a high quantum yield, and the host molecules facilitating an effective host-to-guest energy transfer, as well as effective carrier injection balance.


Subject(s)
Electronics/instrumentation , Light , Lighting/instrumentation , Color , Nanoparticles/chemistry , Temperature
7.
J Chromatogr A ; 1178(1-2): 166-70, 2008 Jan 18.
Article in English | MEDLINE | ID: mdl-18082755

ABSTRACT

Vigabatrin is widely used as an anticonvulsant in the treatment of seizures. Vigabatrin is usually supplied as racemate in formulation, but only the (S)-(+)-enantiomer of vigabatrin is pharmacologically active. A simple and sensitive liquid chromatographic method is described for the separation and quantification of vigabatrin enantiomers. The method is based on derivatizing racemic vigabatrin with a fluorescent chiral reagent (naproxen acyl chloride). The resulting diastereomeric derivatives are highly responsive to a fluorimetric detector (lambda(ex)=230 nm, lambda(em)=350 nm). The lower quantitation limit of the method is attainable at 25 nM for (S)-(+)-vigabatrin or (R)-(-)-vigabatrin with a detection limit of about 2.5 nM (S/N=3 with 10 microl injected). Application of the method to the analysis of vigabatrin in serum of dosed patients proved feasible.


Subject(s)
Anticonvulsants/analysis , Chromatography, High Pressure Liquid , Mass Spectrometry/methods , Vigabatrin/analysis , Anticonvulsants/blood , Anticonvulsants/chemistry , Humans , Naproxen/analogs & derivatives , Naproxen/chemistry , Stereoisomerism , Vigabatrin/blood , Vigabatrin/chemistry
8.
Anal Chim Acta ; 577(2): 201-6, 2006 Sep 08.
Article in English | MEDLINE | ID: mdl-17723672

ABSTRACT

A simple and sensitive liquid chromatographic method is described for the analysis of gamma-amino-n-butyric acid (GABA) in human urine. GABA is increased in the urine of cancer patients and could be used as a biomarker in the diagnosis and treatment of related patients. The method is based on derivatizing GABA with a fluorescent reagent (naproxen acyl chloride) for transforming the non-chromophoric GABA to a derivative with chromophoric and fluorophoric properties. The resulting derivative is highly responsive to a fluorimetric detector (lambda(ex)=230 nm, lambda(em)=350 nm). The lower quantitation of the method is attainable at 100 nM GABA with a detection limit about 10nM (S/N=3 with 20 microL injected). Application of the method to the analysis of GABA in the urine of patients with ovarian and uterine cancer was demonstrated.

SELECTION OF CITATIONS
SEARCH DETAIL
...